Back to 
Point72 Asset Management, L.P.
Point72 Asset Management, L.P.
XERS
Showing 5 of 9 quarters
Position history for Point72 Asset Management, L.P.'s holdings in Xeris Biopharma Holdings, Inc.
No. Point72 Asset Management exited its XERS position in Q1 2026. Its Q4 2025 13F listed 608,080 shares worth $4.8M. Point72 Asset Management first reported XERS in Q4 2022 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$485,166
Total Shares Change
-88,373
Quarter-by-Quarter History